Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1

Astronauts at are risk of losing 1.0–1.5% of their bone mass for every month they spend in space despite their adherence to high impact exercise training programs and diets high in nutrients, potassium, calcium, and vitamin D, all designed to preserve the skeletal system. This article reviews the ba...

Full description

Bibliographic Details
Main Author: John Kelly Smith
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/10/13/4433
id doaj-b4e4a5e9ef6e44ef91547630764ea6ae
record_format Article
spelling doaj-b4e4a5e9ef6e44ef91547630764ea6ae2020-11-25T03:46:46ZengMDPI AGApplied Sciences2076-34172020-06-01104433443310.3390/app10134433Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1John Kelly Smith0Departments of Academic Affairs and Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, P.O. Box 70300, Johnson City, TN 37614, USAAstronauts at are risk of losing 1.0–1.5% of their bone mass for every month they spend in space despite their adherence to high impact exercise training programs and diets high in nutrients, potassium, calcium, and vitamin D, all designed to preserve the skeletal system. This article reviews the basics of bone formation and resorption and details how exposure to microgravity or simulated microgravity affects the structure and function of osteoblasts, osteocytes, osteoclasts, and their mesenchymal and hematologic stem cell precursors. It details the critical roles that insulin-like growth factor-1 and its receptor insulin-like growth factor-1 receptor (GFR1) play in maintaining bone homeostasis and how exposure of bone cells to microgravity affects the function of these growth factors. Lastly, it discusses the potential of tumor necrosis factor-related apoptosis-inducing ligand, syncytin-A, sclerostin inhibitors and recombinant IGF-1 as a bone-saving treatment for astronauts in space and during their colonization of the Moon.https://www.mdpi.com/2076-3417/10/13/4433Insulin-like growth factor-1insulin-like growth factor-1 receptormicrogravityosteoblastsosteocytesosteoclasts
collection DOAJ
language English
format Article
sources DOAJ
author John Kelly Smith
spellingShingle John Kelly Smith
Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1
Applied Sciences
Insulin-like growth factor-1
insulin-like growth factor-1 receptor
microgravity
osteoblasts
osteocytes
osteoclasts
author_facet John Kelly Smith
author_sort John Kelly Smith
title Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1
title_short Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1
title_full Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1
title_fullStr Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1
title_full_unstemmed Microgravity, Bone Homeostasis, and Insulin-Like Growth Factor-1
title_sort microgravity, bone homeostasis, and insulin-like growth factor-1
publisher MDPI AG
series Applied Sciences
issn 2076-3417
publishDate 2020-06-01
description Astronauts at are risk of losing 1.0–1.5% of their bone mass for every month they spend in space despite their adherence to high impact exercise training programs and diets high in nutrients, potassium, calcium, and vitamin D, all designed to preserve the skeletal system. This article reviews the basics of bone formation and resorption and details how exposure to microgravity or simulated microgravity affects the structure and function of osteoblasts, osteocytes, osteoclasts, and their mesenchymal and hematologic stem cell precursors. It details the critical roles that insulin-like growth factor-1 and its receptor insulin-like growth factor-1 receptor (GFR1) play in maintaining bone homeostasis and how exposure of bone cells to microgravity affects the function of these growth factors. Lastly, it discusses the potential of tumor necrosis factor-related apoptosis-inducing ligand, syncytin-A, sclerostin inhibitors and recombinant IGF-1 as a bone-saving treatment for astronauts in space and during their colonization of the Moon.
topic Insulin-like growth factor-1
insulin-like growth factor-1 receptor
microgravity
osteoblasts
osteocytes
osteoclasts
url https://www.mdpi.com/2076-3417/10/13/4433
work_keys_str_mv AT johnkellysmith microgravitybonehomeostasisandinsulinlikegrowthfactor1
_version_ 1724504317782654976